{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_30", "age_group": "21_30", "agreed": true, "close_date_time": "2021-11-7 16:47:58", "close_timestamp": 1638895678364, "created": "07/12/2021 16:47:59", "department": "Psychology", "disability": false, "ease": 1, "environment": "production", "experiment_date_datepicker": "2021-12-07", "gender": "female", "id": "1d6081c1-a8b6-4014-befc-44ce4913d315", "open_date_time": "2021-11-7 16:41:6", "open_timestamp": 1638895266714, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "Anti-viral Research from the University of Monash has shown that Ivermectin can kill COVID-19 within a span of 48-hours.", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 411650, "what": "Ivermectin that kills Covid-19.", "when_happened": "few_month_ago", "where_location": "Monash University study.", "who": "Ivermectin, Dr Kylie Wagstaff.", "why": "To kill of Covid-19 virus."}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_30", "age_group": "21_30", "agreed": true, "close_date_time": "2021-11-7 16:29:13", "close_timestamp": 1638894553860, "created": "07/12/2021 16:29:15", "department": "Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-12-07", "gender": "female", "id": "7121fb3d-0ed2-43ab-9347-e1484d884c05", "open_date_time": "2021-11-7 16:17:50", "open_timestamp": 1638893870947, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "The story above is looking at the Novavax COVID-19 vaccine and whether it is an effective vaccine to be implemented. Trials and testing have been used within the US and Mexico, while more is said to be used outside the US to be used in more places in need. There has been a challenge to this vaccine with the delta variant, so there are questions about whether it is effective, especially with its decreased usage across the US e.t.c.", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 682913, "what": "The Novavax Covid-19 vaccine and its efficacy and use", "when_happened": "few_month_ago", "where_location": "Worldwide (Mexico, South Africa,U.K), mainly the US as its developed there. ", "who": "Novavax, US, COVID-19, other countries receiving the vaccine", "why": "As a vaccine of the pandemic. Whether its effective, "}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_30", "age_group": "21_30", "agreed": true, "close_date_time": "2021-11-7 16:54:28", "close_timestamp": 1638896068450, "created": "07/12/2021 16:54:29", "department": "Psychology", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-12-07", "gender": "female", "id": "8859b15b-6ca2-4ea1-ac31-7cdb37717e56", "open_date_time": "2021-11-7 16:48:5", "open_timestamp": 1638895685313, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Australia GPS have been asked to take part in Ivermectin triple therapy to treat COVID-19. It has been shown to help improve the lives of those experiencing COVID-19. There are some symptoms associated with this therapy but the curing properties have shown to be of much help, hence the Australian government urging GPS to use this therapy. ", "task_condition": "viz", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 383137, "what": "Implementing Ivermectin triple therapy in Australia to combat the COVID-19 pandemic.", "when_happened": "few_month_ago", "where_location": "Australia", "who": "Ivermectin, Australia ", "why": "As this therapy can help fight the coronavirus. "}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_30", "age_group": "21_30", "agreed": true, "close_date_time": "2021-11-7 16:40:50", "close_timestamp": 1638895250859, "created": "07/12/2021 16:40:52", "department": "Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-12-07", "gender": "female", "id": "2db36489-4d88-4d7a-b38c-b30634b5d20d", "open_date_time": "2021-11-7 16:29:24", "open_timestamp": 1638894564966, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "The story above is talking about Ronapreve a cocktail antibody used to treat COVID-19. It was developed by Roche in December 2020 a Japanese pharmaceutical company with the government to combat the virus. It has been shown the help improve the survival rate for those with covid-19 and has been distributed worldwide such as European Union, Canada e.t.c to treat the pandemic. ", "task_condition": "text", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 685893, "what": "It is regarding Ronapreve a antibody cocktail to help combat the COVID-19 pandemic.", "when_happened": "few_years_ago", "where_location": "Japan mainly and worldwide to certain areas to distribute this antibody.", "who": "Roche, Chugai Pharmaceutical, Ronapreve, casirivimab,imdevimab, Japanese government, Covid-19, ", "why": "As it is a way to combat the pandemic and improve the survival rate for those experiencing COVID-19."}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_30", "age_group": "21_30", "agreed": true, "close_date_time": "2021-11-7 17:11:36", "close_timestamp": 1638897096720, "created": "07/12/2021 17:11:38", "department": "Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-12-07", "gender": "female", "id": "8253ab36-a646-440f-a59a-04dfc8c30939", "open_date_time": "2021-11-7 16:54:41", "open_timestamp": 1638896081751, "summary": "Pfizer is a company that has developed a COVID-19 vaccine which has been shown to be one of the most effective vaccines to tackle the COVID-19 pandemic. It has been the first approved vaccine in the UK and has been used worldwide based on its robust \r\neffects to treat the pandemic. Many countries and institutes have supported this vaccine as Mr Bourla has stated that it has shown to have a 'dramatic impact and dramatic potential'. \r\nThere has been a rich collection of data showing its efficacy such as how research has shown that the vaccine can extend to 31 days while being stored which will help preserve it longer and easier. Further research has also shown its robust effectiveness across an Indian strain of COVID-19, which was stronger than the AstraZeneca vaccine.This shows how Pfizer has been one of the worlds leading vaccines.\r\n\r\n", "task_condition": "text", "task_key": "pfizer", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 1014969}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_30", "age_group": "21_30", "agreed": true, "close_date_time": "2021-11-7 17:31:49", "close_timestamp": 1638898309355, "created": "07/12/2021 17:31:51", "department": "Psychology", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-12-07", "gender": "female", "id": "b60c91ad-fd26-4f01-8009-e12ac756f68d", "open_date_time": "2021-11-7 17:11:47", "open_timestamp": 1638897107376, "summary": "The AstraZeneca is a drug produced in the U.K which is used as a vaccine to combat the COVID-19 pandemic. Despite its late development is has shown to be a potent vaccine to treat the pandemic along with some drawbacks associated with it. The vaccine has been used across the globe mainly as one of the main vaccines in the U.K along the Pfizer vaccine and has been distributed worldwide across Europe and the USA and so forth. There has been significant research supporting this vaccine with one piece of research its efficacy in treating an Indian variant of COVID-19 (along with Pfizer). The data shows that AstraZeneca was approximately 60% effective against the strain for two weeks. On the other hand, AstraZeneca has faced controversies with the European Union taking legal action against the distribution of the virus. With the U.K being criticised over 'vaccine nationalism'. Moreover, AstraZeneca has been shown to produce unusual blood clots symptoms questioning the safety of the usage of the vaccine especially to the elderly. However, reports say the positive outweigh the rare blood clot symptoms in which AstraZeneca still being used as a vaccine to treat the Covid-19 vaccine.\r\n", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 1201979}}}